239 related articles for article (PubMed ID: 11438565)
1. Inhibition of murine prostate tumor growth and activation of immunoregulatory cells with recombinant canarypox viruses.
Griffith TS; Kawakita M; Tian J; Ritchey J; Tartaglia J; Sehgal I; Thompson TC; Zhao W; Ratliff TL
J Natl Cancer Inst; 2001 Jul; 93(13):998-1007. PubMed ID: 11438565
[TBL] [Abstract][Full Text] [Related]
2. Effect of canarypox virus (ALVAC)-mediated cytokine expression on murine prostate tumor growth.
Kawakita M; Rao GS; Ritchey JK; Ornstein DK; Hudson MA; Tartaglia J; Paoletti E; Humphrey PA; Harmon TJ; Ratliff TL
J Natl Cancer Inst; 1997 Mar; 89(6):428-36. PubMed ID: 9091644
[TBL] [Abstract][Full Text] [Related]
3. Viral vector delivery in solid-state vehicles: gene expression in a murine prostate cancer model.
Siemens DR; Austin JC; Hedican SP; Tartaglia J; Ratliff TL
J Natl Cancer Inst; 2000 Mar; 92(5):403-12. PubMed ID: 10699070
[TBL] [Abstract][Full Text] [Related]
4. Immunization with type 5 adenovirus recombinant for a tumor antigen in combination with recombinant canarypox virus (ALVAC) cytokine gene delivery induces destruction of established prostate tumors.
Elzey BD; Siemens DR; Ratliff TL; Lubaroff DM
Int J Cancer; 2001 Dec; 94(6):842-9. PubMed ID: 11745487
[TBL] [Abstract][Full Text] [Related]
5. Induction of protective immunity to RM-1 prostate cancer cells with ALVAC-IL-2/IL-12/TNF-alpha combination therapy.
Grant JF; Iwasawa T; Sinn HW; Siemens DR; Griffith TS; Takacs EB; Ratliff TL
Int J Cancer; 2006 Dec; 119(11):2632-41. PubMed ID: 16991124
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of whole-cell tumor preparations infected with the ALVAC viral vector.
Ghose A; Iakhnina E; Spaner D; Tartaglia J; Berinstein NL
Hum Gene Ther; 2000 Jun; 11(9):1289-301. PubMed ID: 10890739
[TBL] [Abstract][Full Text] [Related]
7. Canarypox virus-mediated interleukin 12 gene transfer into murine mammary adenocarcinoma induces tumor suppression and long-term antitumoral immunity.
Puisieux I; Odin L; Poujol D; Moingeon P; Tartaglia J; Cox W; Favrot M
Hum Gene Ther; 1998 Nov; 9(17):2481-92. PubMed ID: 9853515
[TBL] [Abstract][Full Text] [Related]
8. Canarypox virus expressing wild type p53 for gene therapy in murine tumors mutated in p53.
Odin L; Favrot M; Poujol D; Michot JP; Moingeon P; Tartaglia J; Puisieux I
Cancer Gene Ther; 2001 Feb; 8(2):87-98. PubMed ID: 11263530
[TBL] [Abstract][Full Text] [Related]
9. [Poxvirus vectors for gene transfer].
Kawakita M; Yoshida O; Ratliff TL
Hinyokika Kiyo; 1997 Nov; 43(11):835-8. PubMed ID: 9436032
[TBL] [Abstract][Full Text] [Related]
10. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation.
van Elsas A; Hurwitz AA; Allison JP
J Exp Med; 1999 Aug; 190(3):355-66. PubMed ID: 10430624
[TBL] [Abstract][Full Text] [Related]
11. Tumor protection by IL-7 secreting whole cell vaccine is merely mediated by NK1.1-positive cells.
Schroten C; Scheffer R; Boon L; de Ridder CM; Bangma CH; Kraaij R
J Immunother; 2012; 35(2):125-30. PubMed ID: 22306900
[TBL] [Abstract][Full Text] [Related]
12. Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses.
Hodge JW; McLaughlin JP; Kantor JA; Schlom J
Vaccine; 1997; 15(6-7):759-68. PubMed ID: 9178479
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 12-based immunotherapy improves the antitumor effectiveness of a low-dose 5-Aza-2'-deoxycitidine treatment in L1210 leukemia and B16F10 melanoma models in mice.
Kozar K; Kamiński R; Switaj T; Ołdak T; Machaj E; Wysocki PJ; Mackiewicz A; Lasek W; Jakóbisiak M; Gołab J
Clin Cancer Res; 2003 Aug; 9(8):3124-33. PubMed ID: 12912964
[TBL] [Abstract][Full Text] [Related]
14. Immunization of colorectal carcinoma patients with a recombinant canarypox virus expressing the tumor antigen Ep-CAM/KSA (ALVAC-KSA) and granulocyte macrophage colony- stimulating factor induced a tumor-specific cellular immune response.
Ullenhag GJ; Frödin JE; Mosolits S; Kiaii S; Hassan M; Bonnet MC; Moingeon P; Mellstedt H; Rabbani H
Clin Cancer Res; 2003 Jul; 9(7):2447-56. PubMed ID: 12855617
[TBL] [Abstract][Full Text] [Related]
15. Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrate.
Hofbauer GF; Baur T; Bonnet MC; Tartour E; Burg G; Berinstein NL; Dummer R
Melanoma Res; 2008 Apr; 18(2):104-11. PubMed ID: 18337646
[TBL] [Abstract][Full Text] [Related]
16. Liver CD4-CD8- NK1.1+ TCR alpha beta intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro.
Pied S; Roland J; Louise A; Voegtle D; Soulard V; Mazier D; Cazenave PA
J Immunol; 2000 Feb; 164(3):1463-9. PubMed ID: 10640763
[TBL] [Abstract][Full Text] [Related]
17. Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma.
Wong RJ; Patel SG; Kim S; DeMatteo RP; Malhotra S; Bennett JJ; St-Louis M; Shah JP; Johnson PA; Fong Y
Hum Gene Ther; 2001 Feb; 12(3):253-65. PubMed ID: 11177562
[TBL] [Abstract][Full Text] [Related]
18. Mouse NK1.1+ cytotoxic T cells can be generated by IL-2 exposure from lymphocytes which express an intermediate level of T cell receptor.
Ikarashi Y; Maruoka H; Shinohara K; Sugimura T; Terada M; Wakasugi H
Immunol Lett; 1998 Apr; 61(2-3):165-73. PubMed ID: 9657270
[TBL] [Abstract][Full Text] [Related]
19. Superiority of interleukin-12-transduced murine lung cancer cells to GM-CSF or B7-1 (CD80) transfectants for therapeutic antitumor immunity in syngeneic immunocompetent mice.
Sumimoto H; Tani K; Nakazaki Y; Tanabe T; Hibino H; Wu MS; Izawa K; Hamada H; Asano S
Cancer Gene Ther; 1998; 5(1):29-37. PubMed ID: 9476964
[TBL] [Abstract][Full Text] [Related]
20. Oral cytokine gene therapy against murine tumor using attenuated Salmonella typhimurium.
Yuhua L; Kunyuan G; Hui C; Yongmei X; Chaoyang S; Xun T; Daming R
Int J Cancer; 2001 Nov; 94(3):438-43. PubMed ID: 11745427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]